KIAA1549L
gene geneOn this page
Also known as G2MGC34830
Summary
KIAA1549L (KIAA1549 like, HGNC:24836) is a protein-coding gene on chromosome 11p13, encoding UPF0606 protein KIAA1549L (Q6ZVL6).
Predicted to be located in membrane.
Source: NCBI Gene 25758 — RefSeq curated summary.
At a glance
- GWAS associations: 3
- Clinical variants (ClinVar): 288 total
- MANE Select transcript:
NM_012194
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:24836 |
| Approved symbol | KIAA1549L |
| Name | KIAA1549 like |
| Location | 11p13 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | G2, MGC34830 |
| Ensembl gene | ENSG00000110427 |
| Ensembl biotype | protein_coding |
| OMIM | 612297 |
| Entrez | 25758 |
Gene structure
Transcript identifiers
Ensembl transcripts: 3 — 3 protein_coding
ENST00000265654, ENST00000526400, ENST00000658780
RefSeq mRNA: 2 — MANE Select: NM_012194
NM_001410965, NM_012194
CCDS: CCDS44565, CCDS91457
Canonical transcript exons
ENST00000658780 — 21 exons
| Exon | Start | End |
|---|---|---|
| ENSE00000710193 | 33544767 | 33545378 |
| ENSE00000710208 | 33559749 | 33559911 |
| ENSE00000710211 | 33561676 | 33561735 |
| ENSE00000710214 | 33568076 | 33568227 |
| ENSE00000710216 | 33574702 | 33574873 |
| ENSE00000824392 | 33547764 | 33547879 |
| ENSE00000824395 | 33583338 | 33583501 |
| ENSE00001281991 | 33667873 | 33674102 |
| ENSE00001506742 | 33660863 | 33661014 |
| ENSE00001506743 | 33658750 | 33658898 |
| ENSE00001506745 | 33656012 | 33656109 |
| ENSE00001506746 | 33645686 | 33646036 |
| ENSE00001506747 | 33618533 | 33618662 |
| ENSE00001506749 | 33609749 | 33609966 |
| ENSE00001506751 | 33606641 | 33606822 |
| ENSE00001506752 | 33598820 | 33598947 |
| ENSE00001506754 | 33591237 | 33591421 |
| ENSE00001506756 | 33552108 | 33552241 |
| ENSE00001506760 | 33551040 | 33551259 |
| ENSE00003853303 | 33541802 | 33544336 |
| ENSE00003888517 | 33376108 | 33376889 |
Expression profiles
Bgee: expression breadth ubiquitous, 166 present calls, max score 97.25.
FANTOM5 (CAGE): breadth ubiquitous, TPM avg 7.3340 / max 445.0339, expressed in 967 samples.
FANTOM5 promoters (10 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 113676 | 4.2778 | 824 |
| 113675 | 1.3037 | 564 |
| 113679 | 0.5378 | 307 |
| 113674 | 0.3738 | 168 |
| 113673 | 0.1879 | 88 |
| 113680 | 0.1696 | 86 |
| 113678 | 0.1584 | 75 |
| 113677 | 0.1426 | 63 |
| 113681 | 0.1116 | 51 |
| 113682 | 0.0708 | 17 |
Top tissues by expression
273 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| middle temporal gyrus | UBERON:0002771 | 97.25 | gold quality |
| Brodmann (1909) area 23 | UBERON:0013554 | 96.10 | gold quality |
| postcentral gyrus | UBERON:0002581 | 94.75 | gold quality |
| superior frontal gyrus | UBERON:0002661 | 94.47 | gold quality |
| endothelial cell | CL:0000115 | 94.32 | gold quality |
| parietal lobe | UBERON:0001872 | 94.11 | gold quality |
| entorhinal cortex | UBERON:0002728 | 92.81 | gold quality |
| cortical plate | UBERON:0005343 | 90.34 | gold quality |
| primary visual cortex | UBERON:0002436 | 89.84 | gold quality |
| prefrontal cortex | UBERON:0000451 | 88.84 | gold quality |
| occipital lobe | UBERON:0002021 | 88.61 | gold quality |
| frontal cortex | UBERON:0001870 | 87.97 | gold quality |
| frontal lobe | UBERON:0016525 | 87.95 | gold quality |
| dorsolateral prefrontal cortex | UBERON:0009834 | 87.39 | gold quality |
| neocortex | UBERON:0001950 | 86.90 | gold quality |
| right frontal lobe | UBERON:0002810 | 85.96 | gold quality |
| cerebral cortex | UBERON:0000956 | 85.87 | gold quality |
| Brodmann (1909) area 9 | UBERON:0013540 | 85.63 | gold quality |
| secondary oocyte | CL:0000655 | 85.11 | gold quality |
| ganglionic eminence | UBERON:0004023 | 83.22 | gold quality |
| telencephalon | UBERON:0001893 | 82.73 | gold quality |
| cingulate cortex | UBERON:0003027 | 82.19 | gold quality |
| anterior cingulate cortex | UBERON:0009835 | 82.03 | gold quality |
| temporal lobe | UBERON:0001871 | 81.66 | gold quality |
| ventricular zone | UBERON:0003053 | 81.37 | gold quality |
| right hemisphere of cerebellum | UBERON:0014890 | 81.09 | gold quality |
| cerebellar cortex | UBERON:0002129 | 80.97 | gold quality |
| cerebellar hemisphere | UBERON:0002245 | 80.83 | gold quality |
| cerebellum | UBERON:0002037 | 80.67 | gold quality |
| cerebellar vermis | UBERON:0004720 | 80.51 | gold quality |
Single-cell (SCXA)
Detected in 2 experiment(s), a significant marker in 2.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-HCAD-25 | yes | 79.01 |
| E-ANND-3 | yes | 7.39 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
311 targeting KIAA1549L, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-6867-5P | 100.00 | 82.21 | 3464 |
| HSA-MIR-4283 | 100.00 | 66.42 | 2097 |
| HSA-MIR-4262 | 100.00 | 73.26 | 3931 |
| HSA-MIR-6833-3P | 100.00 | 70.63 | 3197 |
| HSA-MIR-4768-5P | 100.00 | 69.49 | 2861 |
| HSA-MIR-4795-3P | 100.00 | 74.62 | 4024 |
| HSA-MIR-6873-3P | 100.00 | 71.42 | 2626 |
| HSA-MIR-126-5P | 100.00 | 72.71 | 3180 |
| HSA-MIR-7110-3P | 100.00 | 73.18 | 2486 |
| HSA-MIR-4481 | 100.00 | 66.42 | 1669 |
| HSA-MIR-5193 | 100.00 | 67.26 | 1744 |
| HSA-MIR-656-3P | 100.00 | 72.15 | 2788 |
| HSA-MIR-3646 | 100.00 | 73.56 | 5283 |
| HSA-MIR-29A-3P | 100.00 | 73.11 | 1835 |
| HSA-MIR-29B-3P | 100.00 | 73.18 | 1833 |
| HSA-MIR-29C-3P | 100.00 | 73.15 | 1833 |
| HSA-MIR-5196-5P | 100.00 | 67.98 | 2761 |
| HSA-MIR-4673 | 100.00 | 66.64 | 1490 |
| HSA-MIR-181A-5P | 99.99 | 72.96 | 2995 |
| HSA-MIR-181B-5P | 99.99 | 72.97 | 2996 |
| HSA-MIR-181C-5P | 99.99 | 72.95 | 2996 |
| HSA-MIR-181D-5P | 99.99 | 73.04 | 2997 |
| HSA-MIR-33A-5P | 99.99 | 68.62 | 1055 |
| HSA-MIR-33B-5P | 99.99 | 68.58 | 1062 |
| HSA-MIR-10401-5P | 99.99 | 65.79 | 948 |
| HSA-MIR-520D-5P | 99.98 | 73.34 | 4883 |
| HSA-MIR-524-5P | 99.98 | 73.43 | 4882 |
| HSA-MIR-4745-5P | 99.98 | 65.95 | 1028 |
| HSA-MIR-4645-5P | 99.98 | 65.81 | 1284 |
| HSA-MIR-607 | 99.97 | 73.62 | 5593 |
Literature-anchored findings (GeneRIF, showing 1)
- Four variants in KIAA1549 like (KIAA1549L), a gene previously associated with attempted suicide in bipolar patients, were suggestively associated with being an owl at p < 1.82E-05; post hoc analyses showed the top variant trending in both the Mexican Americans and American Indians cohorts at p = 2.50E-05 and p = .030, respectively (PMID:29192581)
Cross-species orthologs
4 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | kiaa1549lb | ENSDARG00000062086 |
| danio_rerio | kiaa1549la | ENSDARG00000062477 |
| mus_musculus | D430041D05Rik | ENSMUSG00000068373 |
| rattus_norvegicus | D430041D05Rikl | ENSRNOG00000011132 |
Paralogs (1): KIAA1549 (ENSG00000122778)
Protein
Protein identifiers
UPF0606 protein KIAA1549L — Q6ZVL6 (reviewed: Q6ZVL6)
All UniProt accessions (3): A0A590UJI0, A0A5F9UK30, H0YDE5
UniProt curated annotations — full annotation on UniProt →
Subcellular location. Membrane.
Similarity. Belongs to the UPF0606 family.
Isoforms (2)
| UniProt ID | Names | Canonical? |
|---|---|---|
| Q6ZVL6-1 | 1 | yes |
| Q6ZVL6-2 | 2 |
RefSeq proteins (2): NP_001397894, NP_036326* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR024606 | KIAA1549 | Family |
Pfam: PF12877
UniProt features (22 total): compositionally biased region 8, region of interest 8, splice variant 3, chain 1, transmembrane region 1, coiled-coil region 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q6ZVL6-F1 | 44.78 | 0.05 |
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 137 (showing top):
BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_DN, RIGGI_EWING_SARCOMA_PROGENITOR_UP, TGGAAA_NFAT_Q4_01, MEISSNER_NPC_HCP_WITH_H3K4ME3_AND_H3K27ME3, MIKKELSEN_NPC_HCP_WITH_H3K4ME3_AND_H3K27ME3, CYCLIN_D1_UP.V1_UP, KRAS.300_UP.V1_UP, KRAS.50_UP.V1_UP, KRAS.600_UP.V1_UP, KRAS.600.LUNG.BREAST_UP.V1_UP, KRAS.LUNG_UP.V1_UP, KRAS.LUNG.BREAST_UP.V1_UP, KRAS.PROSTATE_UP.V1_UP, MIR153_5P, MIR6867_5P
GO Biological Process (0):
GO Molecular Function (0):
GO Cellular Component (1): membrane (GO:0016020)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| cellular anatomical structure | 1 |
Protein interactions and networks
STRING
648 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| KIAA1549L | CSTF3 | Q12996 | 909 |
| KIAA1549L | DEPDC7 | Q96QD5 | 873 |
| KIAA1549L | FBXO3 | Q9UK99 | 872 |
| KIAA1549L | CD59 | P13987 | 650 |
| KIAA1549L | LMO2 | P25791 | 528 |
| KIAA1549L | CSTF1 | Q05048 | 496 |
| KIAA1549L | DPRX | A6NFQ7 | 467 |
| KIAA1549L | HIPK3 | Q9H422 | 457 |
| KIAA1549L | C11orf91 | Q3C1V1 | 446 |
| KIAA1549L | M9MMK7 | M9MMK7 | 439 |
| KIAA1549L | CT83 | Q5H943 | 396 |
| KIAA1549L | METAP1 | P53582 | 395 |
| KIAA1549L | DNAJC24 | Q6P3W2 | 377 |
| KIAA1549L | CCDC73 | Q6ZRK6 | 377 |
| KIAA1549L | TCP11L1 | Q9NUJ3 | 375 |
IntAct
6 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| KIAA1549L | H2BC21 | psi-mi:“MI:0915”(physical association) | 0.400 |
| KIAA1549L | psi-mi:“MI:0915”(physical association) | 0.370 | |
| KIAA1549L | FXR1 | psi-mi:“MI:0915”(physical association) | 0.370 |
| GRB2 | KIAA1549L | psi-mi:“MI:0915”(physical association) | 0.000 |
| ATXN1 | KIAA1549L | psi-mi:“MI:0915”(physical association) | 0.000 |
BioGRID (7): KIAA1549L (Proximity Label-MS), KIAA1549L (Two-hybrid), KIAA1549L (Reconstituted Complex), KIAA1549L (Affinity Capture-MS), KIAA1549L (Affinity Capture-RNA), KIAA1549L (Two-hybrid), KIAA1549L (Two-hybrid)
ESM2 similar proteins: A0A1B0GV85, A1KXC4, A6QLF8, B1ARY8, O14594, O35188, O55145, O60279, O60667, O95196, P07141, P09603, P40225, P40226, P42705, P55066, P55067, P70628, P78423, Q149B8, Q17R60, Q28645, Q2LA85, Q2TB54, Q3TNW5, Q52S86, Q58Y74, Q5IS41, Q5M871, Q5R770, Q5T2D2, Q6PIX9, Q6UXF1, Q6ZVL6, Q7Z434, Q80XH2, Q8BHE4, Q8BT18, Q8C0D9, Q8CAE9
Diamond homologs: Q68FD9, Q6ZVL6, Q9HCM3
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
288 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 254 |
| Likely benign | 17 |
| Benign | 4 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
3327 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 11:33547762:A:AG | acceptor_gain | 1.0000 |
| 11:33547763:G:GG | acceptor_gain | 1.0000 |
| 11:33547763:GTT:G | acceptor_gain | 1.0000 |
| 11:33547763:GTTCT:G | acceptor_gain | 1.0000 |
| 11:33547880:G:GG | donor_gain | 1.0000 |
| 11:33552106:A:AG | acceptor_gain | 1.0000 |
| 11:33552106:AGT:A | acceptor_gain | 1.0000 |
| 11:33552107:G:GA | acceptor_gain | 1.0000 |
| 11:33552107:GT:G | acceptor_gain | 1.0000 |
| 11:33552107:GTG:G | acceptor_gain | 1.0000 |
| 11:33552107:GTGCT:G | acceptor_gain | 1.0000 |
| 11:33552205:G:GT | donor_gain | 1.0000 |
| 11:33552206:A:T | donor_gain | 1.0000 |
| 11:33552238:TCAGG:T | donor_loss | 1.0000 |
| 11:33552239:CAGGT:C | donor_loss | 1.0000 |
| 11:33552240:AGGTA:A | donor_loss | 1.0000 |
| 11:33552241:GGTAG:G | donor_loss | 1.0000 |
| 11:33552243:T:G | donor_loss | 1.0000 |
| 11:33559736:T:A | acceptor_gain | 1.0000 |
| 11:33559738:T:TA | acceptor_gain | 1.0000 |
| 11:33559741:T:A | acceptor_gain | 1.0000 |
| 11:33559744:TTCAG:T | acceptor_loss | 1.0000 |
| 11:33559745:TCAGA:T | acceptor_loss | 1.0000 |
| 11:33559746:CAG:C | acceptor_loss | 1.0000 |
| 11:33559747:AGA:A | acceptor_loss | 1.0000 |
| 11:33559748:G:GC | acceptor_gain | 1.0000 |
| 11:33559748:GA:G | acceptor_gain | 1.0000 |
| 11:33559907:TGAAC:T | donor_gain | 1.0000 |
| 11:33559908:GAAC:G | donor_gain | 1.0000 |
| 11:33559908:GAACG:G | donor_gain | 1.0000 |
AlphaMissense
13813 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 11:33574748:T:C | L1129P | 1.000 |
| 11:33574786:G:T | G1142W | 1.000 |
| 11:33583392:C:A | P1189H | 1.000 |
| 11:33583392:C:G | P1189R | 1.000 |
| 11:33591249:T:C | F1230L | 1.000 |
| 11:33591250:T:G | F1230C | 1.000 |
| 11:33591251:T:A | F1230L | 1.000 |
| 11:33591251:T:G | F1230L | 1.000 |
| 11:33609792:G:C | R1405P | 1.000 |
| 11:33609801:T:C | L1408P | 1.000 |
| 11:33668081:T:A | L1826H | 1.000 |
| 11:33668081:T:C | L1826P | 1.000 |
| 11:33668089:G:C | A1829P | 1.000 |
| 11:33668093:T:A | I1830N | 1.000 |
| 11:33668093:T:C | I1830T | 1.000 |
| 11:33668093:T:G | I1830S | 1.000 |
| 11:33668096:G:C | R1831P | 1.000 |
| 11:33668114:T:C | L1837P | 1.000 |
| 11:33552177:T:C | L967P | 0.999 |
| 11:33561723:T:A | W1059R | 0.999 |
| 11:33561723:T:C | W1059R | 0.999 |
| 11:33561725:G:C | W1059C | 0.999 |
| 11:33561725:G:T | W1059C | 0.999 |
| 11:33568148:T:C | L1087P | 0.999 |
| 11:33574753:T:G | Y1131D | 0.999 |
| 11:33574756:T:G | Y1132D | 0.999 |
| 11:33574786:G:A | G1142R | 0.999 |
| 11:33574786:G:C | G1142R | 0.999 |
| 11:33574808:T:C | L1149P | 0.999 |
| 11:33583367:T:A | W1181R | 0.999 |
dbSNP variants (sampled 300 via entrez): RS1000013915 (11:33639186 A>G), RS1000026368 (11:33534985 C>T), RS1000030637 (11:33456473 C>T), RS1000047291 (11:33449882 C>T), RS1000048341 (11:33402744 G>A), RS1000049520 (11:33381433 G>T), RS1000062848 (11:33549187 AT>A), RS1000064645 (11:33418087 T>A), RS1000078956 (11:33402944 T>C), RS1000086675 (11:33528822 G>A), RS1000094279 (11:33593889 T>C,G), RS1000096412 (11:33533766 A>G), RS1000096514 (11:33600547 C>T), RS1000097414 (11:33506560 A>G), RS1000117468 (11:33401688 A>C)
Disease associations
OMIM: gene MIM:612297 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
3 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST001015_2 | Suicide attempts in bipolar disorder | 4.000000e-06 |
| GCST006585_1604 | Blood protein levels | 7.000000e-68 |
| GCST009724_76 | Vertical cup-disc ratio (multi-trait analysis) | 2.000000e-09 |
EFO canonical traits (2, from GWAS)
| EFO ID | Trait name |
|---|---|
| EFO:0004321 | attempted suicide |
| EFO:0006939 | cup-to-disc ratio measurement |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
48 total (human), top 30 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| sodium arsenite | decreases expression, increases abundance, increases expression | 2 |
| belinostat | decreases expression, affects cotreatment | 2 |
| Estradiol | affects expression, affects cotreatment, increases expression | 2 |
| Phenylmercuric Acetate | affects cotreatment, decreases expression | 2 |
| Valproic Acid | decreases expression | 2 |
| aristolochic acid I | decreases expression | 1 |
| FR900359 | increases phosphorylation | 1 |
| bisphenol F | decreases expression, affects cotreatment | 1 |
| propionaldehyde | increases expression | 1 |
| bisphenol A | decreases methylation | 1 |
| trichostatin A | increases expression | 1 |
| methylparaben | decreases expression | 1 |
| benzo(e)pyrene | increases methylation | 1 |
| aflatoxin B2 | increases methylation | 1 |
| 2-palmitoylglycerol | increases expression | 1 |
| 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide | affects cotreatment, decreases expression | 1 |
| abrine | decreases expression | 1 |
| mirdametinib | affects cotreatment, decreases expression | 1 |
| dorsomorphin | decreases expression, affects cotreatment | 1 |
| bisphenol S | decreases methylation | 1 |
| jinfukang | affects cotreatment, decreases expression | 1 |
| (+)-JQ1 compound | affects cotreatment, decreases expression | 1 |
| Resveratrol | affects cotreatment, decreases expression | 1 |
| Temozolomide | decreases expression | 1 |
| Vorinostat | decreases expression | 1 |
| Arsenic | decreases expression, increases abundance | 1 |
| Atrazine | decreases expression | 1 |
| Benzo(a)pyrene | increases methylation | 1 |
| Cadmium | decreases expression, increases abundance | 1 |
| Cisplatin | affects cotreatment, decreases expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.